Ambit to showcase its prevalence projection approach, co-developed with Praxis, for rare developmental and epileptic encephalopathies (DEEs) as a Platform Presentation at this year's annual Child Neurology Society meeting

Reveal Pharmaceuticals doses first subjects in Phase 1 Clinical Trial of RVP-001

Mr. Riley to Lead Corporate Development Efforts as Company Targets New Clinical Applications for its Proprietary, FDA-Cleared Blink Reflex Technology

Jan-Eric Ahlfors, CEO of Fortuna Fix Inc., to present at IABS/CIRM 4th Cell Therapy Conference on June 6, 2018 in Los Angeles

Creators of RealPatientsSpeak Capture Event Highlights for a Close "UP" Look at Patient Centricity: The Present and Future Outlook